Form CORRESP - Correspondence:
SEC Accession No. 0001493152-25-001147
Filing Date
2025-01-07
Accepted
2025-01-07 11:15:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10521
  Complete submission text file 0001493152-25-001147.txt   11750
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)